{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:31:07Z","timestamp":1790364667460,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82004176"],"award-info":[{"award-number":["82004176"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Biology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.repbio.2022.100664","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T13:46:01Z","timestamp":1654695961000},"page":"100664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Conservative surgical and drug therapies for adenomyosis Medicine"],"prefix":"10.1016","volume":"22","author":[{"given":"Yiyue","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaomi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.repbio.2022.100664_bib1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/humupd\/dmz049","article-title":"Diagnosing adenomyosis: an integrated clinical and imaging approach","volume":"26","author":"Chapron","year":"2020","journal-title":"Hum Reprod Update"},{"issue":"6","key":"10.1016\/j.repbio.2022.100664_bib2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/uog.14834","article-title":"Transvaginal sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis: association with symptoms","volume":"46","author":"Pinzauti","year":"2015","journal-title":"Ultrasound Obstetr Gynecol: Off J Int Soc Ultrasound Obstetr Gynecol"},{"issue":"1","key":"10.1016\/j.repbio.2022.100664_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12958-016-0185-6","article-title":"Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease","volume":"14","author":"Puente","year":"2016","journal-title":"Reprod Biol Endocrinol: RB&E"},{"issue":"3","key":"10.1016\/j.repbio.2022.100664_bib4","doi-asserted-by":"crossref","first-page":"hoy011","DOI":"10.1093\/hropen\/hoy011","article-title":"The rate of euploid miscarriage is increased in the setting of adenomyosis","volume":"2018","author":"Stanekova","year":"2018","journal-title":"Hum Reprod Open"},{"issue":"3","key":"10.1016\/j.repbio.2022.100664_bib5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.fertnstert.2018.01.013","article-title":"Role of medical therapy in the management of uterine adenomyosis","volume":"109","author":"Vannuccini","year":"2018","journal-title":"Fertility Sterility"},{"issue":"1","key":"10.1016\/j.repbio.2022.100664_bib6","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1080\/02656736.2021.1967467","article-title":"Clinical evaluation of HIFU combined with GnRH-a and LNG-IUS for adenomyosis patients who failed to respond to drug therapies: two-year follow-up results","volume":"38","author":"Peng","year":"2021","journal-title":"Int J Hyperthermia"},{"issue":"6","key":"10.1016\/j.repbio.2022.100664_bib7","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00404-015-3755-5","article-title":"Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial","volume":"292","author":"Fawzy","year":"2015","journal-title":"Arch Gynecol Obstetr"},{"issue":"2","key":"10.1016\/j.repbio.2022.100664_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5935\/1518-0557.20200104","article-title":"Adenomyosis and in vitro fertilization impacts - A literature review","volume":"25","author":"Squillace","year":"2021","journal-title":"JBRA Assisted Reprod"},{"issue":"6","key":"10.1016\/j.repbio.2022.100664_bib9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/09513590.2019.1683818","article-title":"Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest","volume":"36","author":"Matsushima","year":"2020","journal-title":"Gynecol Endocrinol: Off J Int Soc Gynecol Endocrinol"},{"issue":"1","key":"10.1016\/j.repbio.2022.100664_bib10","article-title":"Efficacy of long-term, low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for adenomyosis","volume":"15","author":"Akira","year":"2009","journal-title":"Med Sci Monit: Int Med J Exp Clin Res"},{"issue":"10","key":"10.1016\/j.repbio.2022.100664_bib11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jogoh.2019.05.003","article-title":"Elasticity of adenomyosis is increased after GnRHa therapy and is associated with spontaneous pregnancy in infertile patents","volume":"48","author":"Xie","year":"2019","journal-title":"J Gynecol Obstetr Hum Reprod"},{"issue":"1","key":"10.1016\/j.repbio.2022.100664_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.12891\/ceog3214.2017","article-title":"Low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for successful long-term management of adenomyosis associated with cerebral venous and sinus thrombosis from low-dose oral contraceptive use","volume":"44","author":"Matsushima","year":"2017","journal-title":"Clin Exp Obstetr Gynecol"},{"issue":"3","key":"10.1016\/j.repbio.2022.100664_bib13","doi-asserted-by":"crossref","first-page":"hoab030","DOI":"10.1093\/hropen\/hoab030","article-title":"A systematic review of outcome reporting and outcome measures in studies investigating uterine-sparing treatment for adenomyosis","volume":"2021","author":"Tellum","year":"2021","journal-title":"Hum Reprod open"},{"issue":"1","key":"10.1016\/j.repbio.2022.100664_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0303-7207(00)00291-4","article-title":"Clinical application of GnRH-antagonists","volume":"166","author":"Felberbaum","year":"2000","journal-title":"Mol Cell. Endocrinol"},{"issue":"1","key":"10.1016\/j.repbio.2022.100664_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJMoa1700089","article-title":"Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist. The","volume":"377","author":"Taylor","year":"2017","journal-title":"New England J Med"},{"issue":"3","key":"10.1016\/j.repbio.2022.100664_bib16","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.fertnstert.2017.01.013","article-title":"Partial suppression of estradiol: a new strategy in endometriosis management?","volume":"107","author":"Donnez","year":"2017","journal-title":"Fertility Sterility"},{"issue":"9","key":"10.1016\/j.repbio.2022.100664_bib17","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/13543784.2021.1957830","article-title":"Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas","volume":"30","author":"Dababou","year":"2021","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"10.1016\/j.repbio.2022.100664_bib18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.xfre.2021.05.004","article-title":"Efficacy and safety of elagolix with add-back therapy in women with uterine fibroids and coexisting adenomyosis","volume":"2","author":"Muneyyirci-Delale","year":"2021","journal-title":"F&S Rep"},{"issue":"1","key":"10.1016\/j.repbio.2022.100664_bib19","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12905-021-01442-x","article-title":"A case of adenomyosis with leiomyoma that was effectively treated with relugolix and kamishoyosan add-on therapy","volume":"21","author":"Sasamori","year":"2021","journal-title":"BMC Women's Health"},{"issue":"3","key":"10.1016\/j.repbio.2022.100664_bib20","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.fertnstert.2020.04.017","article-title":"Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis","volume":"114","author":"Donnez","year":"2020","journal-title":"Fertility sterility"},{"key":"10.1016\/j.repbio.2022.100664_bib21","article-title":"Treatment of symptomatic uterine adenomyosis with linzagolix, an oral gonadotrophin-releasing hormone antagonist: a pilot study","author":"Donnez","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.repbio.2022.100664_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/jcm10245794","article-title":"Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New 'Hit Hard First and then Maintain' Regimen of Administration","volume":"10","author":"Donnez","year":"2021","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.repbio.2022.100664_bib23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.fertnstert.2020.06.003","article-title":"Gonadotropin-releasing hormone antagonist linzagolix: possible treatment for assisted reproduction patients presenting with adenomyosis and endometriosis?","volume":"114","author":"Borini","year":"2020","journal-title":"Fertility Sterility"},{"key":"10.1016\/j.repbio.2022.100664_bib24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejogrb.2014.05.031","article-title":"Progesterone and synthetic progestin, dienogest, induce apoptosis of human primary cultures of adenomyotic stromal cells","volume":"179","author":"Yamanaka","year":"2014","journal-title":"Eur J Obstetr, Gynecol, Reprod Biol"},{"issue":"3","key":"10.1016\/j.repbio.2022.100664_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00404-016-4244-1","article-title":"Endometrial preparation with Dienogest before hysteroscopic surgery: a systematic review","volume":"295","author":"Lagan\u00e0","year":"2017","journal-title":"Arch Gynecol Obstetr"},{"key":"10.1016\/j.repbio.2022.100664_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/1745506520952003","article-title":"Dienogest suppresses cellular proliferation status of endometrial polyps and acts differently depending on the morphological type","volume":"16","author":"Inaba","year":"2020","journal-title":"Women's Health (London, England)"},{"issue":"2","key":"10.1016\/j.repbio.2022.100664_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ijgo.13600","article-title":"Comparison of dienogest versus combined oral contraceptive pills in the treatment of women with adenomyosis: A randomized clinical trial","volume":"154","author":"Hassanin","year":"2021","journal-title":"Int J Gynaecol Obstetr: Off Organ Int Fed Gynaecol Obstetr"},{"issue":"8","key":"10.1016\/j.repbio.2022.100664_bib28","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/jog.13674","article-title":"Long-term dienogest administration in patients with symptomatic adenomyosis","volume":"44","author":"Neriishi","year":"2018","journal-title":"J Obstetr Gynaecol Res"},{"issue":"9","key":"10.1016\/j.repbio.2022.100664_bib29","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/jog.13406","article-title":"Long-term use of dienogest in the treatment of painful symptoms in adenomyosis","volume":"43","author":"Osuga","year":"2017","journal-title":"J Obstetr Gynaecol Res"},{"key":"10.1016\/j.repbio.2022.100664_bib30","first-page":"Cd000068","article-title":"Danazol for pelvic pain associated with endometriosis","volume":"4","author":"Selak","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.repbio.2022.100664_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/ijerph18031235","article-title":"Adenomyosis and Infertility-Review of Medical and Surgical Approaches","volume":"18","author":"Szubert","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"Suppl 1","key":"10.1016\/j.repbio.2022.100664_bib32","first-page":"153","article-title":"[Local administration of danazol on pelvic endometriosis and uterine adenomyosis]","volume":"59","author":"Igarashi","year":"2001","journal-title":"Nihon rinsho Jap J Clin Med"},{"issue":"2","key":"10.1016\/j.repbio.2022.100664_bib33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0015-0282(00)00624-5","article-title":"Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device","volume":"74","author":"Igarashi","year":"2000","journal-title":"Fertility Sterility"},{"issue":"3","key":"10.1016\/j.repbio.2022.100664_bib34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.contraception.2007.05.091","article-title":"Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging","volume":"76","author":"Bragheto","year":"2007","journal-title":"Contraception."},{"issue":"6","key":"10.1016\/j.repbio.2022.100664_bib35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3109\/08977194.2010.511619","article-title":"Effects of LNG-IUS on nerve growth factor and its receptors expression in patients with adenomyosis","volume":"28","author":"Choi","year":"2010","journal-title":"Growth Factors (Chur, Switzerland)"},{"issue":"5","key":"10.1016\/j.repbio.2022.100664_bib36","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/aogs.13798","article-title":"The role of levonorgestrel intra-uterine system in the management of adenomyosis: A systematic review and meta-analysis of prospective studies","volume":"99","author":"Abbas","year":"2020","journal-title":"Acta obstetr gynecol Scand"},{"issue":"2","key":"10.1016\/j.repbio.2022.100664_bib37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.fertnstert.2010.10.009","article-title":"Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis","volume":"95","author":"Ozdegirmenci","year":"2011","journal-title":"Fertility Sterility"},{"issue":"1","key":"10.1016\/j.repbio.2022.100664_bib38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.rbmo.2019.03.101","article-title":"Effect of pretreatment with a levonorgestrel-releasing intrauterine system on IVF and vitrified-warmed embryo transfer outcomes in women with adenomyosis","volume":"39","author":"Liang","year":"2019","journal-title":"Reprod Biomed Online"},{"issue":"08","key":"10.1016\/j.repbio.2022.100664_bib39","first-page":"1216","article-title":"Analysis of the application of collateral-loosening method in adenomyosis based on collateral-disease theory(in Chinese).Chinese","volume":"27","author":"Shi","year":"2021","journal-title":"J Basic Med Traditional Chin Med"},{"issue":"02","key":"10.1016\/j.repbio.2022.100664_bib40","first-page":"150","article-title":"Clinical research on TCM treatment of adenomyosis(in Chinese)","volume":"31","author":"Cheng","year":"2015","journal-title":"Hunan J Traditional Chin Med"},{"issue":"8","key":"10.1016\/j.repbio.2022.100664_bib41","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/s43032-020-00361-w","article-title":"Origin and Pathogenic Mechanisms of Uterine Adenomyosis: What Is Known So Far","volume":"28","author":"Stratopoulou","year":"2021","journal-title":"Reprod Sci (Thousand Oaks, Calif)"},{"issue":"02","key":"10.1016\/j.repbio.2022.100664_bib42","first-page":"292","article-title":"Effects of modified Shaoyaoglycyrrhizae decoction on proliferation and migration of adenomyosis cells ( in Chinese)","volume":"36","author":"XinChan","year":"2018","journal-title":"China J Traditional Chin Med"},{"key":"10.1016\/j.repbio.2022.100664_bib43","unstructured":"Yuyan Z., Kunyin L., Yongge G. Expression of Ras\/Raf\/P-C-Raf in adenomyosis.( in Chinese) Progress in modern obstetrics and gynecology. 2017; 26(07): 517\u2013520."},{"issue":"10","key":"10.1016\/j.repbio.2022.100664_bib44","first-page":"1103","article-title":"Study on molecular mechanism of Guizhi Poria Pill in treatment of adenomyosis based on network pharmacology ( in Chinese) Shandong","volume":"39","author":"Hanlin","year":"2020","journal-title":"J Traditional Chin Med"},{"issue":"07","key":"10.1016\/j.repbio.2022.100664_bib45","first-page":"547","article-title":"Effect of Jiawei Shaoyao Glycyrrhiza Decoction on the proliferation of uterine adenomyocytes by regulating p53\u2013273\u2009h ( in Chinese)","volume":"41","author":"XinChan","year":"2018","journal-title":"J Beijing Univ Traditional Chin Med"},{"issue":"18","key":"10.1016\/j.repbio.2022.100664_bib46","first-page":"3474","article-title":"Research progress of Phytoestrogens in Traditional Chinese medicine ( in Chinese)China","volume":"42","author":"Yuan","year":"2017","journal-title":"J Traditional Chin Med"},{"issue":"01","key":"10.1016\/j.repbio.2022.100664_bib47","first-page":"12","article-title":"Clinical observation on 30 cases of adenomyosis treated with Traditional Chinese Medicine ( in Chinese)","volume":"40","author":"Yunsong","year":"2011","journal-title":"Heilongjiang Traditional Chin Med"},{"issue":"01","key":"10.1016\/j.repbio.2022.100664_bib48","first-page":"62","article-title":"Jawei Siwu decoction in the treatment of 30 cases of uterine adenomyosis ( in Chinese)","volume":"29","author":"Shimei","year":"2013","journal-title":"Hunan J Traditional Chin Med"},{"issue":"33","key":"10.1016\/j.repbio.2022.100664_bib49","first-page":"160","article-title":"Observation on the curative effect of Dane Fukang decoction in the treatment of uterine adenomyosis ( in Chinese)","volume":"5","author":"Yanjuan","year":"2010","journal-title":"China Pract. Med."},{"issue":"2","key":"10.1016\/j.repbio.2022.100664_bib50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jmig.2017.07.014","article-title":"Conservative surgery for adenomyosis and results: a systematic review","volume":"25","author":"Younes","year":"2018","journal-title":"J Minimally Invasive Gynecol"},{"key":"10.1016\/j.repbio.2022.100664_bib51","doi-asserted-by":"crossref","first-page":"8967803","DOI":"10.1155\/2017\/8967803","article-title":"Sonographic Signs of Adenomyosis Are Prevalent in Women Undergoing Surgery for Endometriosis and May Suggest a Higher Risk of Infertility","volume":"2017","author":"Eisenberg","year":"2017","journal-title":"BioMed Res Int"},{"issue":"4","key":"10.1016\/j.repbio.2022.100664_bib52","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/GCO.0000000000000371","article-title":"New paradigms in the conservative surgical and interventional management of adenomyosis","volume":"29","author":"Alvi","year":"2017","journal-title":"Curr Opin Obstetr Gynecol"},{"issue":"1","key":"10.1016\/j.repbio.2022.100664_bib53","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/ajo.12419","article-title":"Association of uterine wall thickness with pregnancy outcome following uterine-sparing surgery for diffuse uterine adenomyosis","volume":"56","author":"Otsubo","year":"2016","journal-title":"Aus New Zealand J Obstetr Gynecol"},{"issue":"9","key":"10.1016\/j.repbio.2022.100664_bib54","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1007\/s00270-017-1686-1","article-title":"Uterine Artery Embolization for Symptomatic Adenomyosis: 7-Year Clinical Follow-up Using UFS-Qol Questionnaire","volume":"40","author":"de Bruijn","year":"2017","journal-title":"Cardiovasc Interv Radiol"},{"issue":"1","key":"10.1016\/j.repbio.2022.100664_bib55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00270-014-0878-1","article-title":"Uterine artery embolisation for symptomatic adenomyosis with polyzene F-coated hydrogel microspheres: three-year clinical follow-up using UFS-QoL questionnaire","volume":"38","author":"Nijenhuis","year":"2015","journal-title":"Cardiovasc Interv Radiol"},{"issue":"7","key":"10.1016\/j.repbio.2022.100664_bib56","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jvir.2011.03.013","article-title":"Uterine artery embolization for the treatment of adenomyosis: a review","volume":"22","author":"Popovic","year":"2011","journal-title":"J Vasc Interv Radiol: JVIR"},{"issue":"4","key":"10.1016\/j.repbio.2022.100664_bib57","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jvir.2012.12.002","article-title":"The impact of uterine artery embolization on ovarian function","volume":"24","author":"Kaump","year":"2013","journal-title":"J Vasc Interv Radiol: JVIR"},{"issue":"2","key":"10.1016\/j.repbio.2022.100664_bib58","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jmig.2019.07.029","article-title":"Is High-intensity Focused Ultrasound Effective for the Treatment of Adenomyosis? A Systematic Review and Meta-analysis","volume":"27","author":"Marques","year":"2020","journal-title":"J Minimally Invasive Gynecol"},{"issue":"11","key":"10.1016\/j.repbio.2022.100664_bib59","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1016\/j.ejrad.2011.05.036","article-title":"Feasibility of MRI-guided high intensity focused ultrasound treatment for adenomyosis","volume":"81","author":"Fan","year":"2012","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1016\/j.repbio.2022.100664_bib60","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/aogs.13159","article-title":"High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility","volume":"96","author":"Zhang","year":"2017","journal-title":"Acta Obstetr Gynecol Scand"},{"issue":"4","key":"10.1016\/j.repbio.2022.100664_bib61","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/1933719118756754","article-title":"Fertility-sparing treatment of adenomyosis in patients with infertility: a systematic review of current options","volume":"25","author":"Rocha","year":"2018","journal-title":"Reprod Sci (Thousand Oaks, Calif)"},{"issue":"5","key":"10.1016\/j.repbio.2022.100664_bib62","first-page":"442","article-title":"Gonadotropin-releasing hormone agonists and laparoscopy in the treatment of adenomyosis with infertility","volume":"113","author":"Lin","year":"2000","journal-title":"Chinese Med J"},{"issue":"05","key":"10.1016\/j.repbio.2022.100664_bib63","first-page":"1129","article-title":"Conservative management of adenomyosis with fertility requirements (in Chinese)","volume":"39","author":"Liangzi","year":"2019","journal-title":"Oncol Pathol"},{"issue":"9","key":"10.1016\/j.repbio.2022.100664_bib64","first-page":"643","article-title":"[Clinical study of high intensity focused ultrasound ablation combined with GnRH-a and LNG-IUS for the treatment of adenomyosis]","volume":"51","author":"Ye","year":"2016","journal-title":"Zhonghua fu chan ke za zhi"},{"issue":"1","key":"10.1016\/j.repbio.2022.100664_bib65","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1080\/02656736.2019.1679892","article-title":"High-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing hormone analogs (GnRHa) and levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis: a case series with long-term follow up","volume":"36","author":"Haiyan","year":"2019","journal-title":"Int J Hyperthermia: Off J Eur Soc Hyperthermic Oncol, North Am Hyperthermia Group"},{"issue":"03","key":"10.1016\/j.repbio.2022.100664_bib66","first-page":"221","article-title":"Study on optimization of clinical diagnosis and treatment process of adenomyosis treated by comprehensive TCM program (in Chinese). Shandong","volume":"40","author":"Wei","year":"2021","journal-title":"J Traditional Chin Med"}],"container-title":["Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1642431X22000638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1642431X22000638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:22:05Z","timestamp":1761646925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1642431X22000638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1642431X22000638"],"URL":"https:\/\/doi.org\/10.1016\/j.repbio.2022.100664","relation":{},"ISSN":["1642-431X"],"issn-type":[{"value":"1642-431X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conservative surgical and drug therapies for adenomyosis Medicine","name":"articletitle","label":"Article Title"},{"value":"Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repbio.2022.100664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Society for Biology of Reproduction & the Institute of Animal Reproduction and Food Research of Polish Academy of Sciences in Olsztyn. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100664"}}